University of Southern California: Breast Neoplasms trials

The registry lists 38 Breast Neoplasms studies with University of Southern California as lead sponsor. 5 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 5Phase 2 6No phase 26(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Breast Cancer Screening Adherence for Women at Moderate Risk for Breast CancerRecruitingNCT07076147
• Access to Genetic Testing in Underserved Patients With CancerRecruitingNCT06422455Not applicable
• A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer DiagnosisRecruitingNCT06336928
• Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast MassesRecruitingNCT06171607Phase 1
• Core Biopsies for Establishing a Breast Tumor Tissue RepositoryRecruitingNCT02250352
• Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast CancerTerminatedNCT01873833Phase 2Results posted
• Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.TerminatedNCT01276054Phase 2Results posted
• Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the BreastTerminatedNCT00556907Not applicableResults posted
• A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)TerminatedNCT00183963Phase 2Results posted
• Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyTerminatedNCT04927559
• 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesCompletedNCT04752267Early Phase 1
• In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsActive, not recruitingNCT04616248Phase 1
• Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate CancerWithdrawnNCT03563352
• Social Media Listening in Improving Clinical Trial Recruitment in Patients With CancerWithdrawnNCT03408561Not applicable
• Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer SurvivorsTerminatedNCT03284346Not applicable
• Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast CancerCompletedNCT03176979Not applicable
• Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast CancerWithdrawnNCT03091842Not applicable
• Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRICompletedNCT02587663Not applicable
• Supportive Care Questionnaires in Gathering Data on Unmet Needs and Health-Related Quality of Life in Latina Breast Cancer Survivors After Surgery, Chemotherapy, or Radiation TherapyCompletedNCT02545023
• Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast CancerTerminatedNCT02483377
• High-Intensity Interval Training for Stage I-III Breast Cancer PatientsTerminatedNCT02454777Not applicable
• Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast CancerCompletedNCT02370277
• Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast CancerTerminatedNCT02370264Not applicable
• Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before SurgeryTerminatedNCT02067884Phase 1
• Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate CancerActive, not recruitingNCT01802346Not applicable
• Light-Scattering Spectroscopy for Detection of Breast CancerTerminatedNCT01755208Not applicable
• PET/CT in Evaluating Response to Chemotherapy in Patients With Breast CancerTerminatedNCT01712815Not applicable
• Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast CancerWithdrawnNCT01695057Not applicable
• Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing ChemotherapyTerminatedNCT01649258Phase 1
• Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By SurgeryWithdrawnNCT01292083Not applicable
• Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerWithdrawnNCT01227408Phase 2
• Endoscopic Breast Surgery in Treating Patients With Breast CancerTerminatedNCT01222377Not applicable
• Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast CancerCompletedNCT01219075Not applicable
• Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
• Exercise Program for Early Breast Cancer SurvivorsCompletedNCT01140282Not applicable
• Green Tea in Breast Cancer PatientsCompletedNCT00949923Not applicable
• Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast CancerTerminatedNCT00159458Phase 2
• Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast CancerCompletedNCT00003050Phase 2